We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00856700
Recruitment Status : Completed
First Posted : March 6, 2009
Last Update Posted : December 11, 2013
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Manfredi Tesauro, University of Rome Tor Vergata

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2012
  Study Completion Date : June 2012